CD8A and non-small cell lung carcinoma: Known risk factors of ICI-related irAEs in NSCLC patients include HLA-I homozygosity [96], BP180-specific immunoglobulin G [97], baseline levels of peripheral CD8+ T cells [98] and gut microbiome [99, 100].